JMT203
JMT203 is a monoclonal antibody from Shanghai JMT-Bio Inc., in registered phase 2 trials for non-small-cell lung cancer, pancreatic ductal adenocarcinoma, colorectal cancer.
Overview
JMT203 is listed on ClinicalTrials.gov as an intervention in 2 registered phase 2 trials sponsored by Shanghai JMT-Bio Inc., in non-small-cell lung cancer, pancreatic ductal adenocarcinoma, colorectal cancer. A monoclonal antibody, as described in the registry record. OnCo records the agent from the registry alone; approvals, results and the sponsor's own description will follow as they are published.
A monoclonal antibody, as described in the registry record.
1.JMT203 binds its target.
Trials
topTrials recruiting now
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Landmark trials
Latest papers
topQuery for this drug: (TITLE:"JMT203" OR ABSTRACT:"JMT203") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about JMT203, not a curated reading list.
Similar pages
not linked directly; found by shared links- TreatmentCT3001
Shares Pancreatic ductal adenocarcinoma, Colorectal cancer and the tags pipeline, registry-only.
- TreatmentLP-184
Shares Pancreatic ductal adenocarcinoma, Non-small-cell lung cancer and the tags pipeline, registry-only.
- TreatmentVB15010
Shares Pancreatic ductal adenocarcinoma, Colorectal cancer and the tags pipeline, registry-only.
- TrialPhase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
Shares Pancreatic ductal adenocarcinoma, Colorectal cancer, Non-small-cell lung cancer and the tag pipeline.
- TrialA Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-pancreatic Neuroendocrine Tumor (GEP-NET)
Shares CSPC Pharmaceutical Group, Pancreatic ductal adenocarcinoma and the tag pipeline.
- TreatmentPBP1510
Shares Pancreatic ductal adenocarcinoma and the tags pipeline, registry-only.
- TreatmentOnvansertib
Shares Colorectal cancer and the tags pipeline, registry-only.
- TreatmentMitazalimab
Shares Pancreatic ductal adenocarcinoma and the tags pipeline, registry-only.